The young man died of acute liver injury, a known side effect, Sarepta said in a statement. But the company said the “severity” of the patient’s case had not previously been seen with the therapy, ...

DWTX READ THE FULL DWTX RESEARCH REPORT Business Update First Patient Dosed in Phase 2b Trial of Halneuron® On March 18, 2025 ...

Sarepta Therapeutics said early Tuesday that a patient had died after receiving its gene therapy Elevidys, which treats the rare genetic condition Duchenne muscular dystrophy. A young man with ...

For 21 years, Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic ...

Dominic, 26, fell ill during the second wave of the pandemic in late 2020, and was in intensive care for three months.

Shares of Sarepta Therapeutics fell after the company said a patient with Duchenne muscular dystrophy died of liver failure after using its Elevidys treatment. The stock opened the market down 22% at ...

The hospital already has created a work station that Palm Beach County sheriff's deputies can use and may hire off-duty ...

Direct-to-patient companies are bringing much-needed disruption to the current healthcare system, challenging payers, ...

A 65-year-old male presented for his annual exam. The medical assistant (MA) checking the patient in remarked that he is asymptomatic except for reporting being a little bit more fatigued than usual.

One patient with Duchenne muscular dystrophy (DMD) has passed away following treatment with Sarepta Therapeutics’ gene therapy Elevidys, the biotech ...

Sarepta Therapeutics' shares have struggled for the past year due to concerns about the commercial potential of its gene therapy and broader pipeline. Safety hadn’t been a major worry for investors—pa ...

International Community Health Services (ICHS) now offers integrative medicine for enrolled patients at our clinics in the ...